Cancers,
Journal Year:
2023,
Volume and Issue:
15(5), P. 1417 - 1417
Published: Feb. 23, 2023
Lactic
acidosis,
a
hallmark
of
solid
tumour
microenvironment,
originates
from
lactate
hyperproduction
and
its
co-secretion
with
protons
by
cancer
cells
displaying
the
Warburg
effect.
Long
considered
side
effect
metabolism,
lactic
acidosis
is
now
known
to
play
major
role
in
physiology,
aggressiveness
treatment
efficiency.
Growing
evidence
shows
that
it
promotes
cell
resistance
glucose
deprivation,
common
feature
tumours.
Here
we
review
current
understanding
how
extracellular
acting
as
combination
enzymatic
inhibitors,
signal,
nutrient,
switch
metabolism
an
oxidative
metabolic
phenotype,
which
allows
withstand
makes
promising
anticancer
target.
We
also
discuss
about
acidosis’
could
be
integrated
whole-tumour
what
perspectives
opens
up
for
future
research.
Journal of Personalized Medicine,
Journal Year:
2025,
Volume and Issue:
15(2), P. 50 - 50
Published: Jan. 27, 2025
Drug
resistance
remains
a
significant
barrier
to
effective
cancer
therapy.
Cancer
cells
evade
treatment
by
reprogramming
their
metabolism,
switching
from
glycolysis
oxidative
phosphorylation
(OXPHOS),
and
relying
on
alternative
carbon
sources
such
as
glutamine.
These
adaptations
not
only
enable
tumor
survival
but
also
contribute
immune
evasion
through
mechanisms
reactive
oxygen
species
(ROS)
generation
the
upregulation
of
checkpoint
molecules
like
PD-L1.
This
review
explores
potential
targeting
metabolic
weaknesses
in
drug-resistant
cancers
enhance
therapeutic
efficacy.
Key
pathways
involved
resistance,
including
glycolysis,
glutamine
kynurenine
pathway,
are
discussed.
The
combination
inhibitors
with
(ICIs),
particularly
anti-PD-1/PD-L1
therapies,
represents
promising
approach
overcoming
both
mechanisms.
Clinical
trials
combining
therapies
have
shown
early
promise,
further
research
is
needed
optimize
combinations
identify
biomarkers
for
patient
selection.
In
conclusion,
metabolism
blockade
offers
novel
drug
providing
pathway
improved
outcomes
Future
directions
include
personalized
treatments
based
profiles
expanding
other
types.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
19(5), P. 5460 - 5474
Published: Jan. 30, 2025
Type-2-diabetes
is
a
metabolic
disorder
where
misfolding
and
oligomerization
of
islet
amyloid
polypeptide
(IAPP)
around
islet-β
cells
oligomerizes
participates
in
the
pathology.
The
oligomeric
stage
toxic
but
transitory
leads
to
formation
mature
fibrils.
pathological
specifics
fibrils
are
poorly
understood.
Here,
we
demonstrate
that
IAPP
amyloids
make
gel-like
transition,
increasing
viscosity
local
microenvironment
encasing
impeding
their
ability
sense
glucose
release
insulin.
Using
dual-targeted
gold
nanoparticles
(AuNPs)
capped
with
amyloid-fragments
βCasein
anti-IAPP
antibodies,
show
X-ray
irradiation
AuNPs
when
bound
results
therapeutic
remodelling
amyloids,
reduction
solution,
restoration
glucose/insulin
homeostasis.
This
study
establishes
can
participate
progressive
pathology
type-2-diabetes
by
suppressing
insulin
responsiveness
at
single
islet-cell
level.
It
also
identifies
model
reversal
using
AuNPs-mediated
therapy,
this
approach
be
rationally
expanded
other
pathologies,
such
as
Alzheimer's
Parkinson's
diseases.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(5), P. 1417 - 1417
Published: Feb. 23, 2023
Lactic
acidosis,
a
hallmark
of
solid
tumour
microenvironment,
originates
from
lactate
hyperproduction
and
its
co-secretion
with
protons
by
cancer
cells
displaying
the
Warburg
effect.
Long
considered
side
effect
metabolism,
lactic
acidosis
is
now
known
to
play
major
role
in
physiology,
aggressiveness
treatment
efficiency.
Growing
evidence
shows
that
it
promotes
cell
resistance
glucose
deprivation,
common
feature
tumours.
Here
we
review
current
understanding
how
extracellular
acting
as
combination
enzymatic
inhibitors,
signal,
nutrient,
switch
metabolism
an
oxidative
metabolic
phenotype,
which
allows
withstand
makes
promising
anticancer
target.
We
also
discuss
about
acidosis’
could
be
integrated
whole-tumour
what
perspectives
opens
up
for
future
research.